How does outdoor air pollution affect your heart, lungs, and brain?

What is measured. PM2.5 means particles smaller than 2.5 micrometres across. The US Air Quality Index (AQI) turns pollutant readings, including ozone and particles, into a six-level scale where 100 matches the short-term health standard¹.

Heart. In 65,893 postmenopausal women in 36 US metro areas, each 10 µg/m³ rise in PM2.5 went with 24% more cardiovascular events and 76% more cardiovascular deaths over a median six years⁶.

Lungs. As southern California air improved over 13 years, the share of 15-year-olds with low lung function fell from 7.9% to 3.6%⁵. In older adults with COPD, a two-hour walk on a London shopping street caused more cough, sputum, and wheeze than a walk in a park².

Cancer. The International Agency for Research on Cancer classes outdoor particulate matter as a Group 1 carcinogen, and a meta-analysis of 18 studies found 9% higher lung cancer risk per 10 µg/m³ of PM2.5⁷.

Brain. Living within 50 metres of a major road went with 7% higher dementia incidence⁸. A review of 66 papers found the weight of evidence suggests PM2.5 contributes to cognitive decline, but strong conclusions remain elusive⁹.

How big is the risk? Among 60 million Medicare enrollees, each 10 µg/m³ rise in PM2.5 went with 7.3% higher all-cause mortality, and the link continued below the US standard¹⁰. A pooled European analysis agreed at low levels¹¹. Particle pollution was the leading single contributor to global disease burden in 2021, at 8.0% of disability-adjusted life years¹². Those are relative risks over years of exposure and population-wide shares, not a verdict on any one day or person.

What helps. Walking and cycling usually win: at the global average urban PM2.5 of 22 µg/m³, activity benefits far outweigh pollution risks, and harms pass benefits only around 100 µg/m³ and after about 1.5 hours of cycling a day³. Where you walk matters: a park walk improved lung function and arterial stiffness for up to 26 hours while a busy-street walk blunted it². At home, filtration helps with particles; see Do Air Purifiers Actually Improve Health?, and for smoke days, Protecting Yourself from Wildfire Smoke. The American Heart Association calls the causal role of PM2.5 in cardiovascular disease unequivocal, yet the evidence for many personal measures limited⁴.

All-cause mortality. Di and colleagues followed 60,925,443 Medicare beneficiaries from 2000 to 2012 (460 million person-years) using ZIP-code exposure models¹⁰. A 10 µg/m³ increase in PM2.5 raised all-cause mortality by 7.3% (95% CI 7.1 to 7.5), and a 10 ppb increase in ozone by 1.1%¹⁰. Restricting to years below 12 µg/m³ and 50 ppb gave 13.6% (13.1 to 14.1) for PM2.5; effects were larger in racial minorities and people with low income¹⁰. The ELAPSE project pooled eight European cohorts (325,367 adults, 19.5 years, 47,131 deaths): 5 µg/m³ more PM2.5 went with 13% (10.6 to 15.5) more natural-cause deaths, and 29.6% (14 to 47.4) among those below 12 µg/m³¹¹.

Cardiovascular disease. The Women's Health Initiative cohort of 65,893 women without prior heart disease found a hazard ratio of 1.24 (1.09 to 1.41) for a first cardiovascular event and 1.76 (1.25 to 2.47) for cardiovascular death per 10 µg/m³, with within-city differences mattering⁶.

Lungs. The Children's Health Study measured lung function in 2,120 children from three cohorts (1994-98, 1997-2001, 2007-11)⁵. Falling nitrogen dioxide and PM2.5 went with better FEV1 and FVC growth between ages 11 and 15, in children with and without asthma; low FEV1 at 15 fell from 7.9% to 6.3% to 3.6%⁵. In the Lancet crossover trial, 119 older adults (40 healthy, 40 with COPD, 39 with ischaemic heart disease) walked two hours on Oxford Street and in Hyde Park². COPD participants reported more sputum (odds ratio 3.15, 1.39 to 7.13) and wheeze (4.00, 1.52 to 10.50) after Oxford Street². Everyone gained lung function and lower arterial stiffness after the park, and those gains were attenuated on the busy street².

Lung cancer. Hamra and colleagues pooled 18 studies: relative risk 1.09 (1.04 to 1.14) per 10 µg/m³ PM2.5, 1.18 (1.00 to 1.39) in never-smokers, and 1.40 (1.07 to 1.83) for adenocarcinoma⁷.

Dementia. In Ontario, about 2.2 million adults aged 55 to 85 were followed from 2001 to 2012, with 243,611 incident dementia cases⁸. The hazard ratio was 1.07 (1.06 to 1.08) within 50 m of a major road, 1.04 within 50 to 100 m, and 1.00 beyond 200 m, stronger in big cities (1.12)⁸. A systematic review of 66 papers, 35 meeting strict quality criteria, supported an adverse association between PM2.5 and cognitive decline, but PM10 and nitrogen oxide findings were inconclusive, and few high-quality studies examined dementia itself⁹.

Exercise trade-offs. A modelling study estimated that at 22 µg/m³ the benefits of cycling and walking far outweigh the risks even at extreme activity levels³. At 100 µg/m³, harms exceed benefits after about 1.5 hours of cycling or 10 hours of walking a day, and results were sensitive to dose-response assumptions³.

Null and conflicting results. Current smokers showed no clear lung-cancer link (1.06, 0.97 to 1.15)⁷. The road-proximity link is small and absent for Parkinson's disease and multiple sclerosis⁸. Dementia reviews flag selection bias and reliance on administrative records⁹. All cohort exposures are modelled estimates at a home address, which misclassifies individual exposure, and no randomized trial of long-term exposure exists, so causation rests on consistency across cohorts, natural experiments, and mechanism^5,10. We found no trial of time of day for outdoor exercise.

Bottom line (confidence 4 of 5). The population-level harm of fine-particle pollution is well established for mortality, heart disease, and lung cancer, and probable for cognitive decline. The relative increase per person is modest, and staying active still wins in most places.